» Articles » PMID: 23043743

Clinical Evaluation of Analytical Variations in Serum Creatinine Measurements: Why Laboratories Should Abandon Jaffe Techniques

Overview
Journal BMC Nephrol
Publisher Biomed Central
Specialty Nephrology
Date 2012 Oct 10
PMID 23043743
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Non-equivalence in serum creatinine (SCr) measurements across Dutch laboratories and the consequences hereof on chronic kidney disease (CKD) staging were examined.

Methods: National data from the Dutch annual external quality organization of 2009 were used. 144 participating laboratories examined 11 pairs of commutable, value-assigned SCr specimens in the range 52-262 μmol/L, using Jaffe or enzymatic techniques. Regression equations were created for each participating laboratory (by regressing values as measured by participating laboratories on the target values of the samples sent by the external quality organization); area under the curves were examined and used to rank laboratories. The 10th and 90th percentile regression equation were selected for each technique separately. To evaluate the impact of the variability in SCr measurements and its eventual clinical consequences in a real patient population, we used a cohort of 82424 patients aged 19-106 years. The SCr measurements of these 82424 patients were introduced in the 10th and 90th percentile regression equations. The newly calculated SCr values were used to calculate an estimated glomerular filtration rate (eGFR) using the 4-variable Isotope Dilution Mass Spectrometry traceable Modification of Diet in Renal Disease formula. Differences in CKD staging were examined, comparing the stratification outcomes for Jaffe and enzymatic SCr techniques.

Results: Jaffe techniques overestimated SCr: 21%, 12%, 10% for SCr target values 52, 73 and 94 μmol/L, respectively. For enzymatic assay these values were 0%, -1%, -2%, respectively. eGFR using the MDRD formula and SCr measured by Jaffe techniques, staged patients in a lower CKD category. Downgrading to a lower CKD stage occurred in 1-42%, 2-37% and 12-78.9% of patients for the 10th and 90th percentile laboratories respectively in CKD categories 45-60, 60-90 and >90 ml/min/1.73 m2. Using enzymatic techniques, downgrading occurred only in 2-4% of patients.

Conclusions: Enzymatic techniques lead to less variability in SCr measurements than Jaffe techniques, and therefore result in more accurate staging of CKD. Therefore the specific enzymatic techniques are preferably used in clinical practice in order to generate more reliable GFR estimates.

Citing Articles

Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetes.

Khan M, Lea J BMC Nephrol. 2024; 25(1):248.

PMID: 39090593 PMC: 11293206. DOI: 10.1186/s12882-024-03652-5.


The Babyccino: The Role of Caffeine in the Prevention of Acute Kidney Injury in Neonates-A Literature Review.

Aithal N, Kandasamy Y Healthcare (Basel). 2024; 12(5).

PMID: 38470639 PMC: 10931184. DOI: 10.3390/healthcare12050529.


Effect of serum creatinine difference between the Jaffe and the enzymatic method on kidney disease detection and staging.

Boss K, Stolpe S, Muller A, Wagner B, Wichert M, Assert R Clin Kidney J. 2023; 16(11):2147-2155.

PMID: 37915891 PMC: 10616437. DOI: 10.1093/ckj/sfad178.


Comparing Jaffe and Enzymatic Methods for Creatinine Measurement at Various Icterus Levels and Their Impacts on Liver Transplant Allocation.

Soleimani N, Dehghani S, Anbardar M, Mohammadzadeh S, Amirinezhad Fard E, Zare Sheibani A Int J Anal Chem. 2023; 2023:9804533.

PMID: 37886708 PMC: 10598504. DOI: 10.1155/2023/9804533.


Perspectives on Chronic Kidney Disease With Type 2 Diabetes and Risk Management: Practical Viewpoints and a Paradigm Shift Using a Pillar Approach.

Morales J, Dagogo-Jack S, Fonseca V, Neumiller J, Rosas S Clin Diabetes. 2023; 41(4):553-566.

PMID: 37849516 PMC: 10577512. DOI: 10.2337/cd22-0110.


References
1.
Levey A, Coresh J, Greene T, Marsh J, Stevens L, Kusek J . Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007; 53(4):766-72. DOI: 10.1373/clinchem.2006.077180. View

2.
Lawson N, Lang T, Broughton A, Prinsloo P, Turner C, Marenah C . Creatinine assays: time for action?. Ann Clin Biochem. 2003; 39(Pt 6):599-602. DOI: 10.1177/000456320203900609. View

3.
Levey A, Bosch J, Lewis J, Greene T, Rogers N, Roth D . A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130(6):461-70. DOI: 10.7326/0003-4819-130-6-199903160-00002. View

4.
Cobbaert C, Baadenhuijsen H, Weykamp C . Prime time for enzymatic creatinine methods in pediatrics. Clin Chem. 2009; 55(3):549-58. DOI: 10.1373/clinchem.2008.116863. View

5.
Dodder N, Tai S, Sniegoski L, Zhang N, Welch M . Certification of creatinine in a human serum reference material by GC-MS and LC-MS. Clin Chem. 2007; 53(9):1694-9. DOI: 10.1373/clinchem.2007.090027. View